by The global intragastric balloon market size reached USD 45 million in 2023 and is projected to hit around USD 108.80 million by 2033, expanding at a CAGR of 9.22% from 2024 to 2033.
Key Points
- By region, North America held the largest share of the intragastric balloon market in 2023 with 38.4%.
- By region, Asia Pacific is expected to witness significant growth during the forecast period.
- By balloon type, in 2023, the single segment held the largest share of 66%.
- By filling material, the saline filled segment held the dominant share of around 73% in 2023.
- By administration, the endoscopy segment held the largest share of over 72.3% in 2023.
- By end use, the hospitals segment has accounted market share of around 55% in 2023.
The intragastric balloon market is a rapidly growing segment within the weight loss and bariatric surgery industry. Intragastric balloons are non-surgical devices inserted into the stomach to help individuals lose weight. These balloons work by taking up space in the stomach, thereby reducing the amount of food a person can eat. As a result, they help individuals achieve significant weight loss without the need for invasive surgical procedures. This market has seen substantial growth in recent years, driven by increasing obesity rates, a growing desire for non-surgical weight loss options, and advancements in medical technology.
Overview
The intragastric balloon market is expanding as obesity and related health issues continue to rise globally. These devices offer a minimally invasive alternative for weight loss, providing patients with a less risky option than traditional bariatric surgeries. The balloons are usually inserted endoscopically and filled with saline or gas, allowing patients to feel fuller quickly and reducing caloric intake. They are typically left in place for six months before being removed. The demand for these devices is rising due to their relative safety, ease of insertion, and effectiveness in promoting weight loss.
Get a Sample: https://www.precedenceresearch.com/sample/4081
Growth Factors
Several factors contribute to the growth of the intragastric balloon market:
- Increasing Obesity Rates: Obesity is a major global health issue, with rising rates of overweight and obese individuals. This creates a larger patient pool seeking weight loss solutions.
- Minimally Invasive Procedures: Patients prefer non-surgical methods for weight loss due to lower risk, reduced recovery time, and fewer complications.
- Technological Advancements: Continuous improvements in balloon design, materials, and insertion techniques enhance patient outcomes and satisfaction.
- Growing Awareness: Increased awareness of the benefits and availability of intragastric balloons as a weight loss option drives market demand.
- Healthcare Reimbursement: In some regions, intragastric balloon procedures are covered by insurance, making them more accessible to patients.
- Rising Prevalence of Lifestyle Diseases: As obesity-related health issues, such as diabetes and cardiovascular diseases, increase, so does the demand for effective weight loss treatments.
Region Insights
The market for intragastric balloons varies by region due to differences in healthcare infrastructure, regulatory environments, and patient demographics.
- North America: The United States and Canada are significant markets due to high obesity rates, advanced healthcare infrastructure, and widespread awareness of intragastric balloon treatments.
- Europe: Countries like Germany, France, and the UK have seen growth in the intragastric balloon market, driven by rising obesity rates and access to advanced medical treatments.
- Asia-Pacific: This region is expected to experience the fastest growth due to increasing healthcare expenditure, rising obesity rates, and growing awareness of weight loss options.
- Latin America and Middle East & Africa: These regions are also expected to see growth in the intragastric balloon market as awareness and healthcare infrastructure improve.
Intragastric Balloon Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 9.22% |
| Global Market Size in 2023 | USD 45 Million |
| Global Market Size in 2024 | USD 49.15 Million |
| Global Market Size by 2033 | USD 108.8 Million |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Balloon Type, By Filling Material, By Administration, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Intragastric Balloon Market Dynamics
Drivers
- Health and Aesthetic Concerns: The desire to improve health and appearance drives demand for weight loss solutions like intragastric balloons.
- Non-Invasive Procedure: The non-surgical nature of intragastric balloon insertion appeals to patients seeking safer weight loss methods.
- Efficacy: Intragastric balloons have been shown to be effective in promoting weight loss, which encourages patient adoption.
- Improved Technology: Advances in intragastric balloon technology enhance patient outcomes and satisfaction, driving market growth.
- Awareness Campaigns: Marketing and awareness campaigns by manufacturers and healthcare providers help educate the public about the benefits of intragastric balloons.
Opportunities
- Product Innovation: Developing new and improved intragastric balloon designs can expand market reach and enhance patient outcomes.
- Expansion in Emerging Markets: Growth opportunities exist in emerging markets with rising obesity rates and increasing healthcare spending.
- Partnerships and Collaborations: Collaborations between medical device companies, healthcare providers, and insurance companies can drive market growth.
- Research and Development: Ongoing research can lead to advancements in intragastric balloon technology and broaden the range of available options.
Challenges
- Regulatory Hurdles: Stringent regulatory requirements can hinder market growth by delaying the approval of new products.
- Reimbursement Issues: Limited insurance coverage for intragastric balloon procedures in certain regions can restrict patient access.
- Competition from Alternative Treatments: The intragastric balloon market faces competition from other weight loss methods, such as medication and surgical procedures.
- Patient Safety and Adverse Effects: Although intragastric balloons are generally safe, there is a risk of complications such as balloon deflation, migration, or perforation.
- Cost of Treatment: The cost of intragastric balloon procedures may be prohibitive for some patients, especially where insurance coverage is limited.
Read Also: Cellular Health Screening Market Size, Growth, Report by 2033
Recent Developments
- In September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India.
Intragastric Balloon Market Companies
- Allurion Technologies
- Allergan (Acquired by Abbott)
- Apollo Endosurgery
- Reshape Medical
- Spatz FGIA
- Endalis
- Silimed
- Medsil
Segment Covered in the Report
By Balloon Type
- Single
- Dual
- Triple
By Filling Material
- Saline Filled
- Gas Filled
By Administration
- Endoscopy
- Pill Form
By End-use
- Hospitals
- Ambulatory Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
